We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Spatial Biology – News and Features

News

Fluidigm Reports Financial Results for First Quarter 2011

Total revenue for the first quarter of 2011 was $8.7 million, an increase of 30% from $6.7 million in the first quarter of 2010.
News

Biophysicist Targeting IL-6 to Halt Breast, Prostate Cancer

OSU’s Li disrupts cellular messages through fragment-based drug design.
News

NIH Study Identifies Gene that Suppresses Cell's Immune Activation

FOXO3 gene suppresses activation of cells related to immunity and thus leads to a reduced immune response against a growing cancer.
News

NIH Study Identifies Gene that Suppresses Cell’s Immune Activation

A new study of prostate tumors has shown that a gene, FOXO3, suppresses activation of cells related to immunity and thus leads to a reduced immune response against a growing cancer.
News

A Targeted Sequencing Approach Powers Three Groundbreaking Human Genetic Studies

Scientists from Leading Institutions to Present Data Demonstrating Impact of Technology in Organ Transplantation, Alzheimer’s, Autism and X-linked Mental Retardation Research.
News

27th Montreux symposium on LC/MS

The 27th Montreux symposium on LC/MS was held from November 10-12th at the Montreux Music & Convention Centre in Montreux, Switzerland. Participants and exhibitors from 36 countries all over the world gathered in the beautiful surroundings of Montreux. This report, written by Jan van der Greef, Chairman Montreux LC/MS symposium, outlines the event.
News

New Data Show Rubicon’s Amplification Technology Enables Genetic and Epigenetic Analyses of Single Cells Using Next-Gen Sequencing

Data show Rubicon’s whole genome and whole Methylome Amplification kits offer key advantages for cancer, stem cell, and embryo studies.
News

Fluidigm Announces Availability of its Summer 2010 Edition of ‘IFC Application Hotspot’ E-newsletter

Issue includes two customer application studies, a recorded video interview with the GIS and a new single-cell gene expression protocol.
News

Rubicon Genomics’ PicoPlex™ Technology Enables International Clinical Genetic Study of Single Human Cells

PicoPlex technology validated for accurate testing of single human cells to diagnose genetic abnormalities in advance of assisted reproduction.
News

Oncomed Pharmaceuticals and Fluidigm Corporation Announce Strategic Collaboration

New initiative will apply Fluidigm’s microfluidic tools to the analysis of tumor cell heterogeneity.
Advertisement